• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[II型糖尿病患者中磺脲类药物与β受体阻滞剂之间可能存在的药理相互作用。病例报告]

[Probable pharmacological interaction between sulfonylurea and beta-blocker in a patient with DM-II. A case report].

作者信息

Centeno-Hoil Gregoreo, Mousavi Homa

机构信息

Farmacéutico comunitario. Farmacia Zarzuelo, Benalmádena (Málaga). Farmacia España.

出版信息

Farm Comunitarios. 2023 Dec 21;16(3):37-42. doi: 10.33620/FC.2173-9218.(2024).11. eCollection 2024 Apr 15.

DOI:10.33620/FC.2173-9218.(2024).11
PMID:39157750
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328701/
Abstract

The study presents the case of a 47-year-old woman with type 2 diabetes (T2D), hypertension and anemia, treated with metformin, glyburide, metoprolol, and iron/folic acid. A drug interaction was identified between glyburide and metoprolol, causing symptoms of hypoglycemia in the afternoon. Evaluation using Horn's Drug Interaction Probability Scale (DIPS) suggested a probable interaction. Pharmacokinetic analysis revealed that the time at which the maximum concentrations of both drugs were reached coincided with the onset of symptoms. A new medication schedule was implemented which resolved the symptoms. The drug interaction was attributed to the blockade of adrenergic effects by metoprolol, compromising the ability to counteract the action of insulin released by glybenclamide. The importance of surveillance, informed decision-making and the implementation of preventive strategies is highlighted to ensure the safety and effectiveness of pharmacological treatment in patients with specific clinical conditions, such as T2D and concomitant cardiovascular diseases.

摘要

该研究报告了一名47岁患有2型糖尿病(T2D)、高血压和贫血的女性病例,她正在接受二甲双胍、格列本脲、美托洛尔以及铁/叶酸治疗。研究发现格列本脲和美托洛尔之间存在药物相互作用,导致患者在下午出现低血糖症状。使用霍恩药物相互作用概率量表(DIPS)进行评估表明这可能是一种相互作用。药代动力学分析显示,两种药物达到最大浓度的时间与症状发作时间一致。实施了新的用药方案后症状得到缓解。这种药物相互作用归因于美托洛尔对肾上腺素能效应的阻断,损害了机体对抗格列本脲释放胰岛素作用的能力。强调了监测、明智决策以及实施预防策略对于确保患有特定临床病症(如T2D和伴发心血管疾病)患者药物治疗的安全性和有效性的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df83/11328701/6da3b280c269/FC16-02-06-gf001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df83/11328701/6da3b280c269/FC16-02-06-gf001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df83/11328701/6da3b280c269/FC16-02-06-gf001.jpg

相似文献

1
[Probable pharmacological interaction between sulfonylurea and beta-blocker in a patient with DM-II. A case report].[II型糖尿病患者中磺脲类药物与β受体阻滞剂之间可能存在的药理相互作用。病例报告]
Farm Comunitarios. 2023 Dec 21;16(3):37-42. doi: 10.33620/FC.2173-9218.(2024).11. eCollection 2024 Apr 15.
2
Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.阿根廷磺脲类药物治疗的2型糖尿病患者样本中低血糖的患病率:糖尿病管理的真实疗效和护理模式(RECAP-DM)研究
Endocrinol Diabetes Nutr (Engl Ed). 2018 Dec;65(10):592-602. doi: 10.1016/j.endinu.2018.05.014. Epub 2018 Jul 31.
3
Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.格列美脲与格列本脲治疗非胰岛素依赖型糖尿病的双盲对照临床研究。格列美脲/格列本脲研究组
Horm Metab Res. 1996 Sep;28(9):426-9. doi: 10.1055/s-2007-979831.
4
Use oral hypoglycemics with caution..谨慎使用口服降糖药。
Geriatrics. 1988 Aug;43(8):77-83.
5
Combination therapy with insulin glargine plus metformin but not insulin glargine plus sulfonylurea provides similar glycemic control to triple oral combination therapy in patients with type 2 diabetes uncontrolled with dual oral agent therapy.对于使用两种口服药物治疗血糖仍未得到控制的2型糖尿病患者,甘精胰岛素联合二甲双胍治疗而非甘精胰岛素联合磺脲类药物治疗能提供与三联口服联合治疗相似的血糖控制效果。
J Diabetes Complications. 2015 Nov-Dec;29(8):1266-71. doi: 10.1016/j.jdiacomp.2015.05.022. Epub 2015 Jun 5.
6
Ibuprofen-related hypoglycemia in a patient receiving sulfonylurea.一名接受磺脲类药物治疗的患者出现与布洛芬相关的低血糖症。
Ann Intern Med. 2001 Feb 20;134(4):344. doi: 10.7326/0003-4819-134-4-200102200-00027.
7
Severe sulfonylurea-induced hypoglycemia: a problem of uncritical prescription and deficiencies of diabetes care in geriatric patients.严重的磺酰脲类药物引起的低血糖:老年患者处方不谨慎和糖尿病护理不足的问题。
Expert Opin Drug Saf. 2010 Sep;9(5):675-81. doi: 10.1517/14740338.2010.492777.
8
Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Piragliatin, a Glucokinase Activator, and Glyburide, a Sulfonylurea, in Type 2 Diabetic Patients.吡格列酮、一种葡萄糖激酶激活剂和格列本脲、一种磺酰脲类药物在 2 型糖尿病患者中的药代动力学和药效学药物相互作用研究。
Clin Pharmacol Drug Dev. 2016 Nov;5(6):552-556. doi: 10.1002/cpdd.276. Epub 2016 Jun 28.
9
[Hardly any hypoglycemias, constant weight--and still cost effective].几乎没有低血糖情况,体重稳定——且仍具成本效益。
MMW Fortschr Med. 2005 Nov 24;147(47):72-3.
10
Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.与 2 型糖尿病患者的梨果仙人掌、格列吡嗪和二甲双胍相关的低血糖不良药物反应。
Ann Pharmacother. 2010 Jul-Aug;44(7-8):1334-7. doi: 10.1345/aph.1P148. Epub 2010 Jun 1.

本文引用的文献

1
Metoprolol prevents neuronal dendrite remodeling in a canine model of chronic obstructive sleep apnea.美托洛尔可预防犬慢性阻塞性睡眠呼吸暂停模型中的神经元树突重塑。
Acta Pharmacol Sin. 2020 May;41(5):620-628. doi: 10.1038/s41401-019-0323-8. Epub 2019 Dec 20.
2
Hypoglycemia in diabetes: The dark side of diabetes treatment. A patient-centered review.糖尿病患者低血糖:糖尿病治疗的阴暗面。以患者为中心的综述。
J Diabetes. 2019 Sep;11(9):711-718. doi: 10.1111/1753-0407.12933. Epub 2019 May 27.
3
Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes.
肾上腺素:低血糖和糖尿病中其代谢作用的见解
Br J Pharmacol. 2016 May;173(9):1425-37. doi: 10.1111/bph.13458. Epub 2016 Mar 8.
4
Proposal for a new tool to evaluate drug interaction cases.关于评估药物相互作用病例的新工具的提议。
Ann Pharmacother. 2007 Apr;41(4):674-80. doi: 10.1345/aph.1H423. Epub 2007 Mar 27.